Alyeska Investment Group, L.P.

Position in NKTX — Nkarta, Inc.

CIK 1453072 CHICAGO, IL

Position in NKTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,372,097

-$3,026,915 QoQ

Shares Held

484,840

-76.7% QoQ

Ownership

0.677%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#23

of 136 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. NKTX ranks #69 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	659,279	$123,469,771
2	IONS	Ionis Pharmaceuticals Inc	1,417,916	$112,426,559
3	PTGX	Protagonist Therapeutics, Inc	889,298	$109,010,148
4	XENE	Xenon Pharmaceuticals Inc.	697,692	$42,112,689
5	MRNA	Moderna, Inc.	560,819	$39,274,154
6	KYMR	Kymera Therapeutics, Inc.	276,455	$31,701,094
7	LBRX	Lb Pharmaceuticals Inc	863,947	$28,039,399
8	PRAX	Praxis Precision Medicines, Inc.	80,846	$27,066,432

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,372,097	484,840	-76.7%	Shares	Sole	2026-08-14
2026-03-31	$4,399,012	2,084,840	0.0%	Shares	Sole	2026-05-15
2025-12-31	$3,856,954	2,084,840	+0.0%	Shares	Sole	2026-02-13
2025-09-30	$4,315,320	2,084,696	0.0%	Shares	Sole	2025-11-17
2025-06-30	$3,460,595	2,084,696	+1.0%	Shares	Sole	2025-08-14
2025-03-31	$3,799,519	2,064,956	+54.7%	Shares	Sole	2025-05-15
2024-12-31	$3,323,393	1,334,696	+23.0%	Shares	Sole	2025-02-14
2024-09-30	$4,902,825	1,084,696	+18.5%	Shares	Sole	2024-11-14
2024-06-30	$5,409,907	915,382	+70.3%	Shares	Sole	2024-08-14
2024-03-31	$5,811,239	537,580	+19.3%	Shares	Sole	2024-05-15
2023-12-31	$2,974,824	450,731	-54.9%	Shares	Sole	2024-02-14
2023-09-30	$1,390,000	1,000,000	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.